Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Prizes for Matthias Mann; a New CEO at Quest; and More

Premium

Matthias Mann, director of the Max Planck Institute of Biochemistry, has been awarded the 2012 Louis-Jeantet Prize for Medicine and the 2012 Ernst Schering Prize for his work developing mass spectrometry procedures for protein analysis and methods for large-scale proteomics.

Mann also serves as coordinator for the European Commission's PROSPECTS – Proteomics Specification in Time and Space – program.


Quest Diagnostics has named Stephen Rusckowski as president and CEO, succeeding Surya Mohapatra. He will also become a member of the board of directors.

Rusckowski is currently CEO of Philips Healthcare. Before that he held a variety of management positions in the healthcare division of Hewlett-Packard/Agilent Technologies.

Quest also announced that Daniel Stanzione will become non-executive chairman of the board.


The Critical Path Institute has chosen Steven Broadbent as its new chief operating officer. Broadbent will take over for Rick Myers, who recently stepped down from the post in order to focus on his role as chairman of the Arizona Board of Regents. Myers will remain a member of C-Path's board of directors.

Since early 2009, Broadbent has been the director of consortia operations at the institute. Before joining C-Path, Broadbent was an executive at IBM for nearly 31 years.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.